Chase Investment Counsel’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-510
| Closed | -$536K | – | 146 |
|
|
2024
Q3 | $536K | Sell |
510
-97
| -16% | -$102K | 0.18% | 85 |
|
|
2024
Q2 | $637K | Hold |
607
| – | – | 0.23% | 87 |
|
|
2024
Q1 | $584K | Buy |
+607
| New | +$584K | 0.22% | 92 |
|
|
2022
Q3 | – | Sell |
-798
| Closed | -$471K | – | 110 |
|
|
2022
Q2 | $471K | Hold |
798
| – | – | 0.25% | 67 |
|
|
2022
Q1 | $557K | Hold |
798
| – | – | 0.24% | 64 |
|
|
2021
Q4 | $503K | Buy |
+798
| New | +$503K | 0.2% | 72 |
|
|
2021
Q1 | – | Sell |
-1,606
| Closed | -$775K | – | 116 |
|
|
2020
Q4 | $775K | Sell |
1,606
-3,730
| -70% | -$1.8M | 0.34% | 59 |
|
|
2020
Q3 | $2.99M | Sell |
5,336
-489
| -8% | -$274K | 1.49% | 25 |
|
|
2020
Q2 | $3.63M | Sell |
5,825
-1,331
| -19% | -$830K | 1.84% | 15 |
|
|
2020
Q1 | $3.49M | Buy |
+7,156
| New | +$3.49M | 2.36% | 18 |
|